Features

Agency 2016 Pharma Report: All the data in one place

2016 Pharma Report: All the data in one place

Learn more about the top therapeutic categories by sales, top companies by revenue, top drugs by sales, and more.

Features

2016 Pharma Report: Index of top 20 drugmakers

The index of the top 20 drugmakers from the 2016 pharma report.

Corporate

20. Bristol-Myers Squibb

Immuno-oncology was the story at Bristol-Myers Squibb in 2015.

Corporate

19. Valeant

So, heard anything lately about Valeant? Yeah. Even by the standards of an industry under siege, Valeant experienced quite the tumultuous last year or so.

Corporate

18. Biogen

Biogen's 2015 was hindered by less-than-stellar sales of its flagship multiple sclerosis treatment Tecfidera.

Corporate

17. Mylan

After turning its back on an offer from generics competitor Teva, Mylan stepped up with an unsuccessful hostile takeover bid for generic drugmaker Perrigo.

Corporate

16. Boehringer Ingelheim

In an effort to overcome pricing pressures and bounce back from patent losses, Germany's second-largest drugmaker has unloaded assets and reshuffled its management team.

Corporate

15. GlaxoSmithKline

The year 2015 was one of restructuring for GlaxoSmithKline.


The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.